Authors
Kwaku Twum, PhD
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Kimberly Burgos Villar, PhD
Memorial Sloan Kettering Cancer Center
New York, New York
Yanchun Lin, PhD
Washington University in St Louis School of Medicine
St. Louis, Missouri
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
· evaluate diagnostic decisions of physicians for patients with high suspicion of Myasthenia Gravis (MG);
· educate lab personnel and physicians on limitations of serology testing for diagnosing MG;
· interpret the clinical significance of electromyography and nerve conduction studies to diagnose seronegative MG; and
· advise on the different modalities and effectiveness of various treatment options for MG symptoms.